期刊
CURRENT OPINION IN PEDIATRICS
卷 21, 期 3, 页码 373-378出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MOP.0b013e32832b4171
关键词
pediatric cancer; pediatric tumors; rhabdomyosarcoma; soft tissue sarcoma
类别
资金
- NIH University of Texas MD Anderson Cancer Center
Purpose of review Rhabdomyosarcoma is a rare childhood cancer that affects only approximately 300 children per year in the United States. The purpose of this review is to provide the reader a greater understanding of the complex diagnosis, assessment and treatment of rhabdomyosarcoma in children. Recent findings This review focusses on the new risk classification that is the foundation of all present rhabdomyosarcoma protocols developed by the Children's Oncology Group of the United States and Canada. The new risk classification of low, intermediate and high encompasses the staging and grouping categories that were previously utilized. Summary This review also provides a complete list of diagnostic tests and imaging required to identify rhabdomyosarcoma in any body site. Rapid diagnosis and recognition of this rare disorder will facilitate long-term survival. Rhabdomyosarcoma today has an overall survival of 70%, depending on the site, and in orbital and other sites survival is as high as 90%. The treatment approaches that have led to this doubling in survival over the last 25 years are reviewed. For a practitioner, this review can be used as a reference when a child with a suspicious mass is encountered.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据